Researchers comparing DSIP and Selank are usually mapping which compound fits a given neuropeptide research question. This is descriptive reference information about how they differ, not guidance or a recommendation. Both are sold strictly for in-vitro laboratory research and are not for human or veterinary use.
| DSIP | Selank | |
|---|---|---|
| Type | Nonapeptide (delta sleep-inducing peptide) | Heptapeptide tuftsin analog |
| Primary research area | Sleep-regulation and stress-signaling models | Anxiolytic-pathway and neuroimmune models |
| Handling | Lyophilized; store frozen | Lyophilized; store frozen |
DSIP is a nonapeptide studied in neuroendocrine, sleep-regulation, and stress-response research in animal models.
DSIP product page and batch COA · DSIP reconstitution guide
Selank is a tuftsin-analog heptapeptide studied in anxiolytic-pathway and neuroimmune research.
Selank product page and batch COA · Selank reconstitution guide
Both are short neuropeptides but studied in different pathways: DSIP in sleep/stress-signaling research, Selank in anxiolytic and neuroimmune research. Researchers select by the pathway their model targets.
DSIP is a sleep-related nonapeptide studied in neuroendocrine research; Selank is a tuftsin-analog heptapeptide studied in anxiolytic-pathway and neuroimmune research.
Both are research neuropeptides but from different origins and studied in different pathways.
No. Both are sold strictly for in-vitro laboratory research and are not for human or veterinary use.